Dowsett M - Search Results

1

Premenopausal mammographic density in relation to cyclic variations in endogenous sex hormone levels, prolactin, and insulin-like growth factors.

Walker K, Fletcher O, Johnson N, Coupland B, McCormack VA, Folkerd E, Gibson L, Hillier SG, Holly JM, Moss S, Dowsett M, Peto J, dos Santos Silva I. Walker K, et al. Among authors: dowsett m. Cancer Res. 2009 Aug 15;69(16):6490-9. doi: 10.1158/0008-5472.CAN-09-0280. Cancer Res. 2009. PMID: 19679547

2

Steroid and growth factor modulation of aromatase activity in MCF7 and T47D breast carcinoma cell lines.

Ryde CM, Nicholls JE, Dowsett M. Ryde CM, et al. Among authors: dowsett m. Cancer Res. 1992 Mar 15;52(6):1411-5. Cancer Res. 1992. PMID: 1311630

3

Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment.

Butta A, MacLennan K, Flanders KC, Sacks NP, Smith I, McKinna A, Dowsett M, Wakefield LM, Sporn MB, Baum M, et al. Butta A, et al. Among authors: dowsett m. Cancer Res. 1992 Aug 1;52(15):4261-4. Cancer Res. 1992. PMID: 1322240

4

Dowsett M, Cunningham DC, Stein RC, Evans S, Dehennin L, Hedley A, Coombes RC. Dowsett M, et al. Cancer Res. 1989 Mar 1;49(5):1306-12. Cancer Res. 1989. PMID: 2917360 Clinical Trial.

5

Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer.

Johnston SR, Saccani-Jotti G, Smith IE, Salter J, Newby J, Coppen M, Ebbs SR, Dowsett M. Johnston SR, et al. Among authors: dowsett m. Cancer Res. 1995 Aug 1;55(15):3331-8. Cancer Res. 1995. PMID: 7614468

6

Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancer.

Daffada AA, Johnston SR, Smith IE, Detre S, King N, Dowsett M. Daffada AA, et al. Among authors: dowsett m. Cancer Res. 1995 Jan 15;55(2):288-93. Cancer Res. 1995. PMID: 7812959

7

Clinical and endocrine effects of the oral aromatase inhibitor vorozole in postmenopausal patients with advanced breast cancer.

Johnston SR, Smith IE, Doody D, Jacobs S, Robertshaw H, Dowsett M. Johnston SR, et al. Among authors: dowsett m. Cancer Res. 1994 Nov 15;54(22):5875-81. Cancer Res. 1994. PMID: 7954417 Clinical Trial.

8

Phase I study of the oral nonsteroidal aromatase inhibitor CGS 20267 in postmenopausal patients with advanced breast cancer.

Iveson TJ, Smith IE, Ahern J, Smithers DA, Trunet PF, Dowsett M. Iveson TJ, et al. Among authors: dowsett m. Cancer Res. 1993 Jan 15;53(2):266-70. Cancer Res. 1993. PMID: 8417819 Clinical Trial.

9

Comparison of estrogen receptor DNA binding in untreated and acquired antiestrogen-resistant human breast tumors.

Johnston SR, Lu B, Dowsett M, Liang X, Kaufmann M, Scott GK, Osborne CK, Benz CC. Johnston SR, et al. Among authors: dowsett m. Cancer Res. 1997 Sep 1;57(17):3723-7. Cancer Res. 1997. PMID: 9288779

10

Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.

Johnston SR, Boeddinghaus IM, Riddler S, Haynes BP, Hardcastle IR, Rowlands M, Grimshaw R, Jarman M, Dowsett M. Johnston SR, et al. Among authors: dowsett m. Cancer Res. 1999 Aug 1;59(15):3646-51. Cancer Res. 1999. PMID: 10446976

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

740 results

Search Page

Filters